Related Experiment Video For Basal cell carcinoma
Updated: Jul 1, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Aggressive basal cell carcinoma in a non-facial location in a cat: Perineural and lymphatic invasion with metastasis
Kenichi Maeda1, Naomi Kawasaki2, Satomi Iwai1
1Department of Small Animal Surgery 2, Kitasato University School of Veterinary Medicine, Towada, Japan.
Background:
Basal cell carcinomas (BCCs) in cats are generally regarded as benign skin tumors with low metastatic potential. However, rare cases of aggressive behavior and metastasis, primarily in the context of facial lesions, have been reported.
Case Description:
A 12-year-old neutered male Scottish Fold cat presented with a chronic, non-healing ulcer on the left hock. The initial excision lacked a histopathological diagnosis, and the lesion recurred. Biopsy of the lesion confirmed basal cell carcinoma. Despite limb amputation with clear margins and no regional lymph node involvement, distant cutaneous nodules appeared 6 months later and were histologically confirmed as metastatic BCC with lymphatic and perineural invasion. Wide-margin resections and systemic chemotherapy with carboplatin were performed; however, further lesions developed, and the cat succumbed to progressive disease.
Conclusion:
This case highlights a rare and aggressive variant of feline BCC arising outside the head and neck region. The lesion demonstrated metastatic spread, perineural and lymphatic invasion, and a poor response to treatment. Early histopathological evaluation of chronic skin ulcers is essential, and recognition of aggressive subtypes may facilitate more effective clinical management.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
